EcoDrugPlus

Toll Like Receptor 8

Ensembl ID : ENSHCOG00000004040
Gene Symbol: TLR8
4 Cross references
187 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSHCOG00000009779
Gene Symbol: LOC109508419
3 Cross references
199 Possible Orthologues:

Transmembrane O-Methyltransferase-Like

Ensembl ID : ENSHCOG00000010185
Gene Symbol: LOC109526256
2 Cross references
177 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSHCOG00000007983
Gene Symbol: LOC109529786
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSHCOG00000020222
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 1a

Ensembl ID : ENSHCOG00000008897
Gene Symbol: TUBA1A
3 Cross references
142 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSHCOG00000017595
Gene Symbol: TUBA4A
3 Cross references
170 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSHCOG00000020356
Gene Symbol: TUBA4A
3 Cross references
110 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSHCOG00000010010
Gene Symbol: LOC109518174
2 Cross references
119 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSHCOG00000016328
Gene Symbol: LOC109529243
2 Cross references
119 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSHCOG00000015729
Gene Symbol: TUBB4B
1 Cross references
138 Possible Orthologues:

Tubulin Beta Chain

Ensembl ID : ENSHCOG00000012363
Gene Symbol: LOC109531637
3 Cross references
160 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).